Management tracks: Amgen’s Meline retiring; plus BlackThorn, Rheos, Novartis, Kintai, Myriad, Avrobio, Oncorus, Moberg, Achilles and Aerpio

Amgen Inc. (NASDAQ:AMGN) said EVP and CFO David Meline will retire at year end. The pharma hired Peter Griffith as EVP, finance and said he will succeed Meline as CFO on Jan. 1. Griffith was president of private equity firm Sherwood Canyon Group.

BlackThorn Therapeutics Inc. promoted co-founder William Martin to CEO and appointed him to the board. He was the company’s president and COO, as well as CSO. Prior to BlackThorn’s founding, he was executive director at Theravance Biopharma Inc. (NASDAQ:TBPH). BlackThorn is a computational sciences company developing therapies for neurobehavioral disorders...